Clear cell renal cell carcinoma cerebellar metastases

• Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases
• Detection of Small Brain Metastases by 18 F-Thretide PET/CT in Clear Cell Renal Cell Carcinoma
• A Cerebellar Tumor-to-Tumor Metastasis in a Patient With Von Hippel-Lindau Disease
• Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease
• A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin
• Cerebellar Metastases from Prostate Cancer Detected by PET/CT with (18)F-Choline
• Simultaneous Bilateral Testicular Metastases from Renal Clear Cell Carcinoma: A Rare Presentation in Von Hippel-Lindau disease
• Metastasis of Renal Cell Carcinoma to Spinal Hemangioblastoma in a Patient with von Hippel-Lindau Disease: A Case Report

Clear cell renal cell carcinoma (CCRCC) is a type of kidney cancer that can spread (metastasize) to other parts of the body, including the brain. Cerebellar metastases occur when cancer cells from the kidney spread to the cerebellum.

Symptoms of cerebellar metastases from CCRCC can include headaches, nausea, vomiting, dizziness, difficulty with balance and coordination, and changes in vision or hearing. Treatment options for cerebellar metastases may include surgery, radiation therapy, and chemotherapy, depending on the size and location of the metastases and the overall health of the patient.